Come up with a name for your new list and we'll add to it:
Deciphera Pharmaceuticals raised a round of funding on July 18, 2011. Investors include
Kansas Bioscience Authority.
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by tackling key mechanisms of drug resistance that limit the rate and/or durab…